American Marconi Wireless News

NYSE - LSE

BCE	-1.9%	21.62	$
CMSC	-0.35%	20.05	$
NGG	-3.33%	83.15	$
BCC	-5%	70.24	$
RIO	0.68%	83.73	$
RBGPF	0%	75.17	$
JRI	1.81%	11.63	$
GSK	-0.16%	50.33	$
CMSD	-0.1%	20.15	$
RELX	-3.19%	40.17	$
RYCEF	0.3%	16.43	$
VOD	-2.37%	15.58	$
AZN	-0.23%	186.43	$
BP	-0.38%	44.53	$
BTI	-3.6%	60.89	$

Featured

Katy Perry Tells Fans Ex-Husband Russell Brand 'Should Be in Jail' During UK Concert

Katy Perry has recalled a past concert moment where she told fans that her ex-husband Russell Brand 'should be in jail,' a statement that has taken on renewed significance following his recent criminal convictions. The singer made the remark during a question-and-answer session at the Blenheim Palace Festival last July, before Brand was found guilty of rape and sexual assault.

George and Amal Clooney attend New York political-comedy reading

George and Amal Clooney attended a performance at New York’s Seaview Studio where the actor took part in a reading of the political comedy Smear!

Last news

Snapshot Recipes AI Turns Refrigerator Photos Into Personalized Recipes From Virtually Any Cuisine

Medical Care Technologies (OTC PINK: MDCE) accelerates social media expansion and user engagement initiatives.

Smart Money Media Expands AEO and GEO Practice as AI Search Reshapes How Brands are Discovered

Smart Money Media Combines Tier-One Earned Editorial With Answer Engine and Generative Engine Optimization to Help Brands Get Cited Inside AI Assistants

MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy

Randomized, double-blind, placebo-controlled study to evaluate safety, tolerability, and dose-response efficacy of oral Ketamir-2 at a leading U.S. cancer center

Moderna to Host Investor Event - Science Day

CAMBRIDGE, MA / ACCESS Newswire / June 17, 2026 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Science Day at 9:00am ET on Thursday, June 25, 2026.

Global Stem Cells Group (OTC:RMTG) Launches ISSCA Mobile App, Advancing Its Buildout of a Global Digital Ecosystem for Regenerative Medicine

New physician-facing platform digitizes a 30+ country network and lays the foundation for ISSCA AI™, positioning RMTG at the intersection of regenerative medicine and scalable health technology

CTT Pharma Signs LOI with European Company

TAMPA, FL / ACCESS Newswire / June 17, 2026 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has signed an LOI with a company in the United States to conduct clinical trials and testing for several potential nicotine products for CTT Pharma. A partnership with this company would allow CTT the ability to independently go to market in the United States utilizing our patented technology. CTT Pharma will notify shareholders as more information becomes available.

InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 17

LONDON, UK / ACCESS Newswire / June 17, 2026 / The Company announces that on 16 June 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.

Genflow Biosciences PLC - Company to present at Animal Longevity Summit 2026

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Former DEA Section Chief Steps Forward to Challenge Marijuana Rescheduling Process

"As DEA Prepares for June 29 Hearing, MMJ International Holdings Brings Forward the Very Experts Who Built, Enforced, and Understand the Federal Drug Approval System" stated Duane Boise CEO MMJ International Holdings.

EU admits it can't save discontinued video games

It's game over for fans of discontinued video games after the EU admitted defeat on Tuesday and said it cannot stop publishers making them unplayable.

India braces for El Nino-linked dry conditions

India will prepare contingency plans to help farmers weather potential low rainfall linked to the El Nino weather system, agriculture officials said Tuesday.

Restoring Kyiv cathedral hit by Russia could take two years: director

It could take around two years to repair Kyiv's Dormition Cathedral and its surrounding monastery complex after they were damaged in a Russian attack, its director said Tuesday.

Vast areas of coral reef could resist climate change: study

In the crystalline waters off Kenya's coast, coral reefs are thriving -- evidence of a rare good news story in the battle to protect oceans from the ravages of climate change.

INEO Tech Corp. Announces Closing of Private Placement and Debt Settlement

SURREY, BC / ACCESS Newswire / June 16, 2026 / INEO Tech Corp. (TSXV:INEO)(OTCQB:INEOF, currently trading as INEOD until early July 2026 due to the recent share consolidation) (the "Company" or "INEO") announces that further to its news releases dated May 4, 2026, and May 28, 2026, the Company closed its previously announced non-brokered private placement of Shares (the "Share Offering"), issuing 15,000,000 Shares, at a price of $0.10 per Share for gross proceeds of $1,500,000.

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization

VANCOUVER, BC / ACCESS Newswire / June 16, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce, further to its news release dated November 18, 2025, the completion of its pilot project with Kuano Ltd. ("Kuano"), supporting the continued advancement of Onco's PNKP Inhibitor Technology (also known as ONC010) through advanced AI-enabled and quantum-based computational approaches.

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results

Revenues increased 48% in Q4 2026 compared to Q4 2025, and 37% in FY 2026 compared to FY 2025United States revenues increased 194% in Q4 2026 compared to Q4 2025 and 117% in FY 2026 compared to FY 2025Net loss improved 25% in Q4 2026 compared to Q4 2025, and 8% in FY 2026 compared to FY 2025EBITDA loss improved 66% in Q4 2026 compared to Q4 2025, and 38% in FY 2026 compared to FY 2025

Nickelodeon 90's Mash-up Candle Collection Launches Exclusively at GooseCreek.com

LIBERTY, KY / ACCESS Newswire / June 16, 2026 / Goose Creek is bringing the ultimate throwback experience home with the launch of its new Nickelodeon 90's Mash-up Candle Collection, inspired by the unforgettable shows, characters, colors, and chaos that defined an entire generation of television fans.

Jeffery Miglicco Co-Authors Amazon Best-Selling Leadership Book with Chris Voss

Jeffery Miglicco joins national best-selling author status with former FBI hostage negotiator Chris Voss in a new business book exploring empathy, accountability, and leadership performance.

On Sale Now! LiberNovo Maxis Big & Tall Ergonomic Chair Debuts, Unlocking a New Level of "Stability, Width, and Comfort" for Prolonged Sitting

The Maxis series is live today across the US, Canada, and Europe, starting at US$809, with launch savings up to 44% off MSRP.

HonorBridge Names Joel Baucom Chief Operating Officer

CHAPEL HILL, NC / ACCESS Newswire / June 16, 2026 / HonorBridge is pleased to announce that Joel Baucom, M.Div., has been named Chief Operating Officer. Baucom brings 15 years of experience at HonorBridge to the role, having served in a variety of positions across the organization, including Family Support Coordinator, Manager of Family Services, Director of Organ Operations and Director of Partner Engagement.

Medical Care Technologies (OTC PINK:MDCE) Discusses Enterprise-Grade Privacy Architecture for MDCE Melanoma Scan Beta

Company discusses secure image handling, privacy-focused platform architecture, and future compliance-oriented development initiatives

Barefoot Risks: Why Summer Activities Can Lead to Hidden Foot Injuries, According to Ankle & Foot Centers of America

ATLANTA, GA / ACCESS Newswire / June 16, 2026 / As temperatures rise and more people spend time outdoors, Ankle & Foot Centers of America is encouraging individuals to be mindful of the hidden risks that summer activities can pose to foot health.

MIB Agents' Community of Families Has Awarded $2.9M in Grants to Research Pediatric Bone Cancer

Leading Pediatric Osteosarcoma Nonprofit to Present $400,000 to 5 Scientists During Annual Conference to Find Kinder Treatments for Patients

Dolphin Subsidiary 42West's 25th Tribeca Film Festival Slate Delivered a Standout Film Slate Featuring 16 Film and TV Titles

Activities Included Appearances by Clients Martin Scorsese, Rebecca Miller, Marc Maron; Films by Sean Ono Lennon, Andrew Neel, Sam Pollard, Sophia Takal; World Premiere of Prime Video Series 'Every Year After,' and Much More

SoCal Aesthetic Surgery Expands Treatment Options With Addition of CO₂ SmartXide PRO Laser

The addition of SmartXide PRO expands non-surgical skin rejuvenation options for patients seeking improved tone, texture, and collagen renewal.

Armanino Foods Announces Board Transition and Appointment of Richard Armanino and Trish Lukasik to Board of Directors

PLEASANTON, CA / ACCESS Newswire / June 16, 2026 / Armanino Foods of Distinction, Inc. (OTCQX:AMNF), a leading producer of frozen pesto, sauces, and Italian specialty food products, today announced the retirement of Directors Deb Armanino LeBlanc and Albert S. Banisch Jr. and the appointment of Richard Armanino and Trish Lukasik to its Board of Directors, effective immediately.

TRNR to Report Second Quarter 2026 Results on August 14, 2026; Expects Record Quarterly Revenue of Approximately $8 Million

Company Expects Q2 Adjusted EBITDA Loss of Less than $1 Million and 2026 Full Year Pro Forma Revenue of More Than $30 MillionRun-rate Adjusted EBITDA Profitability Expected by Year EndM&A Activity Continues with Two LOI's submitted in May

Black Book Study Finds Europe is Connected, But Not Yet Interoperable: Only 13% of Healthcare IT Users Say Vendors are EHDS-Ready

Following the Brussels EHDS interoperability meeting, Black Book's Q2 vendor-agnostic survey identifies Europe's EHDS-ready countries and vendors, and where real-world data exchange still lags

NextBoat Inc.'s Autograph Yachts Division Delivers Strong Second Quarter Growth, Driven by Expanding Brokerage Platform and Market Share Gains

Division surpasses $132 million in total transaction volume since launch, exceeding first-year target by more than 30%

Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028

Dr. Stephen Hoge, President of Moderna, to Assume an Expanded Role With Operational Oversight of the Company's Infectious Disease, Intismeran and Rare Disease FranchisesEster Banque to Join Moderna as Chief Commercial Officer

Cannabis Industry Attorney Concedes D.C. Circuit Challenge Could Reverse Marijuana Rescheduling

"For weeks investors have been told that the legal challenges to marijuana rescheduling were merely procedural speed bumps. Now a respected cannabis industry attorney has acknowledged what MMJ has maintained all along: if the D.C. Circuit reaches the merits, the Schedule III order faces substantial legal risk. Courts decide cases based on law and evidence-not industry wishful thinking," said Duane Boise, CEO of MMJ International Holdings.

Teknova Expands Digital Publication Experience with Bioz Content Hub Integration

PALO ALTO, CA / ACCESS Newswire / June 16, 2026 / Bioz, Inc., an innovative platform focused on extracting and syndicating insights from scientific publications, announced its continued collaboration with Teknova, a leading manufacturer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Building on a long-standing collaboration, Teknova has expanded its use of Bioz Badges by implementing a fully customized Bioz Content Hub, creating a centralized, standalone destination for publication data across its product portfolio.

American Marconi Wireless News - Boulevard (English)